# US 2019/0316196 A1 · Transposition of Native Chromatin for Personal Epigenomics

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0316196 A1
- Document ID: US20190316196A1
- Status: Published application
- Kind: A1
- Application number: 16/418,796
- Filed: 2019-05-21
- Published: 2019-10-17
- Earliest claimed: 2013-05-23
- Assignees: The Board of Trustees of the Leland Stanford Junior University
- Applicants: The Board of Trustees of the Leland Stanford Junior University
- Inventors: Paul Giresi; Jason D. Buenrostro; Howard Y. Chang; William J. Greenleaf
- Web page: https://patentgrep.com/patent/US20190316196A1

## CPC

- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6869: Methods for sequencing
- G16B 20/00: ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B 30/00: ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems
- C12Q 2521/301: Endonuclease
- C12Q 2537/164: Methylation detection other then bisulfite or methylation sensitive restriction endonucleases
- Y02A 90/10: Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

Provided herein is a method for analyzing polynucleotides such as genomic DNA. In certain embodiments, the method comprises: (a) treating chromatin isolated from a population of cells with an insertional enzyme complex to produce tagged fragments of genomic DNA; (b) sequencing a portion of the tagged fragments to produce a plurality of sequence reads; and (c) making an epigenetic map of a region of the genome of the cells by mapping information obtained from the sequence reads to the region. A kit for performing the method is also provided.

## Claims

### Claim at position 1

1-97. (canceled)

### Claim 98

A composition comprising:
a permeabilized cell nucleus comprising a plurality of polynucleotide molecules;
an insertional enzyme complex; and
an insert element comprising at least one nucleic acid comprising a predetermined sequence.

### Claim 99 (depends on 98)

The composition of claim 98, further comprising a permeabilization agent selected from the group consisting of: NP40, digitonin, tween, steptolysin, cationic lipids, and any combination thereof.

### Claim 100

A composition comprising:
a permeabilized cell nucleus comprising a plurality of polynucleotide molecules, wherein the plurality of polynucleotide molecules comprises genomic DNA comprising a plurality of open chromatin regions;
an insertional enzyme complex; and
an insert element comprising at least one nucleic acid comprising a predetermined sequence.

### Claim 101 (depends on 100)

The composition of claim 100, wherein the insertional enzyme complex comprises one or more enzymatic moieties.

### Claim 102 (depends on 101)

The composition of claim 101, wherein the insertional enzyme complex comprises two or more enzymatic moieties.

### Claim 103 (depends on 102)

The composition of claim 102, wherein the two or more enzymatic moieties are linked together.

### Claim 104 (depends on 100)

The composition of claim 100, wherein the insertional enzyme complex comprises a nuclear localization signal.

### Claim 105 (depends on 100)

The composition of claim 100, wherein the insertional enzyme complex is configured to insert a nucleic acid sequence into at least one of the polynucleotide molecules.

### Claim 106 (depends on 105)

The composition of claim 105, wherein the insertional enzyme complex is configured to insert the nucleic acid sequence into at least one of the polynucleotide molecules in a substantially sequence independent manner.

### Claim 107 (depends on 100)

The composition of claim 100, wherein the insertional enzyme complex comprises an enzyme selected from the group consisting of: transposases, HERMES, and HIV integrases.

### Claim 108 (depends on 107)

The composition of claim 107, wherein the insertional enzyme complex comprises a transposase.

### Claim 109 (depends on 108)

The composition of claim 108, wherein the transposase is a Tn transposase.

### Claim 110 (depends on 109)

The composition of claim 109, wherein the Tn transposase is selected from the group consisting of: Tn3, Tn5, Tn7, Tn10, Tn552 and Tn903.

### Claim 111 (depends on 110)

The composition of claim 110, wherein the transposase is a Tn5 transposase.

### Claim 112 (depends on 100)

The composition of claim 100, wherein the insert element comprises one or more molecular tags.

### Claim 113 (depends on 112)

The composition of claim 112, wherein one or more of the molecular tags comprises a sequencing adaptor.

### Claim 114 (depends on 113)

The composition of claim 113, wherein one or more of the sequencing adaptors comprises a barcode label.

### Claim 115

A composition comprising:
a permeabilized cell nucleus;
an insertional enzyme complex comprising a transposase enzyme; and
a plurality of tagged nucleic acid fragments, wherein each tagged nucleic acid fragment comprises a first sequencing adapter and a second sequencing adapter;
wherein each tagged nucleic acid fragment is derived from a region of open chromatin.

### Claim 116 (depends on 115)

The composition of claim 115, wherein the plurality of tagged nucleic acid fragments correspond to two or more regions of a genome.

### Claim 117 (depends on 115)

The composition of claim 115, wherein the plurality of tagged nucleic acid fragments correspond to at least 1,000 regions of a genome.

### Claim 118 (depends on 117)

The composition of claim 117, wherein the plurality of tagged nucleic acid fragments correspond to genome-wide regions of open chromatin.

### Claim 119 (depends on 117)

The composition of claim 117, wherein the transposase is a Tn transposase.

### Claim 120 (depends on 119)

The composition of claim 119, wherein the Tn transposase is a Tn5 transposase.

### Claim 121

A composition comprising:
a permeabilized cell nucleus;
an insertional enzyme complex comprising a transposase enzyme; and
a plurality of tagged nucleic acid fragments, wherein each tagged nucleic acid fragment comprises a first sequencing adapter and a second sequencing adapter;
wherein the insertional enzyme complex and the tagged nucleic acid fragments are bound to one or more regions of open chromatin within the cell nucleus in a substantially sequence independent manner to form a high affinity macromolecule complex.

### Claim 122 (depends on 121)

The composition of claim 121, further comprising a plurality of divalent cations.

### Claim 123 (depends on 122)

The composition of claim 122, wherein the divalent cations are not chelated.

### Claim 124 (depends on 122)

The composition of claim 122, wherein the divalent cations are selected from the group consisting of: magnesium, manganese, or any combination thereof.

### Claim 125 (depends on 121)

The composition of claim 121, wherein the transposase is a Tn transposase.

### Claim 126 (depends on 125)

The composition of claim 125, wherein the Tn transposase is selected from the group consisting of: Tn3, Tn5, Tn7, Tn10, Tn552 and Tn903.

### Claim 127 (depends on 126)

The composition of claim 126, wherein the transposase is a Tn5 transposase.
